Search Tag: precision medicine
2025 20 May
Sepsis and Acute Respiratory Distress Syndrome (ARDS) are heterogeneous critical illness syndromes. Molecular subphenotyping shows promise in furthering our understanding of these syndromes and may offer a more precise method for identifying appropriate therapies. Current Definitions of Sepsis and Acute Respiratory Distress Syndrome...Read more
2025 13 May
Pulmonary hypertension (PH) remains a critical health concern, affecting approximately 1% of the global population and up to 10% of older adults. Characterised by vascular remodelling and right-sided heart failure, PH has a poor prognosis if not diagnosed early. Traditional diagnostic approaches, particularly right heart catheterisation (RHC),...Read more
2025 17 Mar
Recent advancements in medical imaging have opened new possibilities for cancer diagnosis. Researchers at Empa have developed a novel 3D tissue analysis method for thyroid tumours using X-ray phase-contrast micro-computed tomography (micro-CT). This technology, enhanced by artificial intelligence, enables faster and more precise diagnoses without...Read more
2025 04 Mar
Companion diagnostics have revolutionised cancer care by enabling precision medicine, ensuring that treatments are tailored to individual patients. These diagnostic tools help identify biomarkers that predict how a patient will respond to a specific therapy, allowing for more effective and safer treatment plans. Over the past 25 years, companion...Read more
2025 04 Mar
Companion diagnostics have revolutionised cancer care by enabling precision medicine, ensuring that treatments are tailored to individual patients. These diagnostic tools help identify biomarkers that predict how a patient will respond to a specific therapy, allowing for more effective and safer treatment plans. Over the past 25 years, companion...Read more
2025 03 Mar
The process of drug discovery is fraught with inefficiencies, with nearly 90% of drug candidates failing to make it beyond clinical trials. This high failure rate not only inflates costs, reaching an estimated €2.12 billion ($2.3 billion) per successful drug, but also delays the availability of effective treatments. A primary cause of this inefficiency...Read more
2025 26 Feb
During the European Congress of Radiology 2025, prominent experts examined significant advancements in nuclear medicine, emphasising theranostics, radiotracer safety protocols and clinical trial management methodologies. The discussions underscored the integration of cutting-edge technologies aimed at refining precision medicine and optimising...Read more
2025 04 Feb
Affidea Group, the pan-European provider of specialist healthcare services, including cancer care, advanced diagnostic imaging and community-based polyclinics , announced today the acquisition of Instituts für histologische und zytologische Diagnostik AG, in Switzerland. This acquisition adds two high-quality pathology laboratories...Read more
2024 16 Dec
Artificial intelligence (AI) is rapidly reshaping the healthcare industry, with its integration into clinical decision support systems (CDSS) marking a significant advancement in patient care. These systems, designed to assist healthcare professionals with evidence-based insights, are essential in improving diagnostic accuracy, optimising treatment...Read more
2024 16 Dec
Artificial intelligence (AI) is rapidly reshaping the healthcare industry, with its integration into clinical decision support systems (CDSS) marking a significant advancement in patient care. These systems, designed to assist healthcare professionals with evidence-based insights, are essential in improving diagnostic accuracy, optimising treatment...Read more
2024 16 Dec
Artificial intelligence (AI) is rapidly reshaping the healthcare industry, with its integration into clinical decision support systems (CDSS) marking a significant advancement in patient care. These systems, designed to assist healthcare professionals with evidence-based insights, are essential in improving diagnostic accuracy, optimising treatment...Read more
2024 09 Dec
Colorectal cancer (CRC) is a significant global health challenge, being the third most prevalent malignancy and the second leading cause of cancer-related mortality. A primary complication in CRC management is the development of liver metastases, which affect approximately 50% of patients, either postoperatively or during later stages of the disease....Read more
2024 30 Nov
Gastric cancer represents a formidable challenge in global healthcare, being the fifth most common cancer worldwide and the fourth leading cause of cancer-related deaths. The disease's prognosis is heavily dependent on early diagnosis and accurate staging, yet achieving this remains complex due to the asymptomatic nature of early stages and the...Read more
2024 18 Nov
AlphaFold3, the latest evolution of DeepMind’s groundbreaking AI tool for protein-structure prediction, is now more accessible to the academic community. With its ability to model proteins in complex environments, AlphaFold3 is a powerful asset for advancing medical research, particularly drug discovery. Although the tool’s code has been made...Read more
2024 16 Nov
The convergence of artificial intelligence and precision healthcare is reshaping modern medicine, allowing for highly personalised treatment approaches that improve patient outcomes and operational efficiency. Advancements in AI-driven genomic analysis, blockchain technology for data security and multi-omic integration are setting new standards...Read more
2024 16 Nov
The convergence of artificial intelligence and precision healthcare is reshaping modern medicine, allowing for highly personalised treatment approaches that improve patient outcomes and operational efficiency. Advancements in AI-driven genomic analysis, blockchain technology for data security and multi-omic integration are setting new standards...Read more
2024 09 Jul
Dr. Sarma brings exceptional expertise in all facets of the pharmaceutical and biotechnology business, from scaling platforms to developing therapeutics STALICLA SA, a Swiss neuro precision biotech company dedicated to developing precision medicine-based treatments for neurodevelopmental and neuropsychiatric disorders, such as autism...Read more
2024 14 Jun
The European Society of Radiology (ESR) is pleased to announce the launch of a new Thematic Network dedicated to advancing precision medicine for cancer patients in Europe through AI-powered imaging. The network was launched following a successful proposal submission by the ESR and Cancer Image Europe (EUCAIM) on the EU Health Policy Platform....Read more
2024 19 Apr
The Radical Health Festival Helsinki 2024, a premier event in the health innovation calendar, is set to commence with an opening by two distinguished figures in the health sector. Finland’s Minister of Social Affairs and Health, Sanni Grahn-Laasonen, and Bavaria’s Minister of Health, Judith Gerlach, will jointly inaugurate the event on Tuesday,...Read more
2024 13 Feb
An innovative initiative utilising artificial intelligence (AI) to tailor therapies for patients with cardiovascular disease was kicked off at a meeting in Utrecht, the Netherlands. Funded by €7.6 million from the EU's Horizon Europe programme, the NextGen project will be executed by a 21-member consortium, including the European Society...Read more
2024 13 Feb
An innovative initiative utilising artificial intelligence (AI) to tailor therapies for patients with cardiovascular disease was kicked off at a meeting in Utrecht, the Netherlands. Funded by €7.6 million from the EU's Horizon Europe programme, the NextGen project will be executed by a 21-member consortium, including the European Society...Read more
2023 30 Oct
This year in 2023, United Imaging has disrupted the molecular imaging industry once again with our innovative technologies. At EANM 2023, we showcased the uMI Panorama™ PET/CT family to the world. The uMI Panorama is breaking barriers in all directions with industry-leading PET image quality, the finest NEMA NU 2-2018 PET spatial resolution at...Read more
2023 28 Aug
On Saturday, August 26, 2023, Philips researchers presented data at the European Society of Cardiology Congress in Amsterdam demonstrating how specific diagnostic referral codes [1] can potentially help to pre-determine how long a cardiology patient should receive mobile telemetry, or Holter monitoring, to monitor their symptoms remotely and possibly...Read more
2022 26 Aug
Philips AI-powered interventional and diagnostic smart systems and at-home solutions connect care across the cardiology care pathway to enhance diagnostic confidence, drive greater efficiency, and improve patient outcomes Royal Philips , a global leader in health technology, will showcase its latest integrated cardiology solutions...Read more
2022 13 Jun
OneOncology, the national platform for independent oncology practices appointed Thomas Stricker , MD as Medical Director for Precision Medicine. Dr. Stricker will work with partner practices to create workflows that reduce physicians' burden of genomic test ordering and interpretation, so they have more time to spend with their patients. Dr. Stricker...Read more
2019 25 Jun
Artificial intelligence (AI) is increasingly used in healthcare, from improving the diagnosis of disease to making innovations in treatment. The role of AI in advancing precision medicine was the focus of a recent conference in Boston organised by Harvard Medical School. You might also like: AI in Medical Imaging May Make the...Read more
2018 31 Oct
Leading a healthy lifestyle is key to both preventing and treating a host of chronic diseases, including cardiovascular disease (CVD). The incidence and prevalence of CVD is at the forefront of conditions that require significant attention and a paradigm shift in treatment, according to an article published in the journal Current Problems in Cardiology. ...Read more
2018 06 Jun
Radiomics is a hot topic in radiology. A steadily increasing number of researchers across the globe is engaging in radiomics and applying it to a large number of imaging data. “Radiomics” means the extraction of a large number of quantitative imaging features from routinely acquired imaging data (e.g, x-ray, ultrasound, CT, MRI, PET) in order to...Read more